Related Experiment Videos
Ischemically mediated sustained monomorphic ventricular tachycardia. Resolution with anti-ischemic therapy
R W Peters1, H J Kim, G A Buser
1Department of Medicine, Baltimore Veterans Administration Medical Center.
Chest
|November 1, 1993
Summary
This study details a patient experiencing ventricular tachycardia due to myocardial ischemia. Aggressive anti-ischemic therapy proved effective when other treatments failed, suggesting its benefit for similar arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Ischemic Heart Disease
Background:
- Malignant ventricular arrhythmias can be precipitated by myocardial ischemia.
- Standard antiarrhythmic and interventional treatments may not always be effective.
Observation:
- A patient presented with sustained monomorphic ventricular tachycardia at rest, unresponsive to intravenous procainamide.
- Initial percutaneous transluminal coronary angioplasty provided temporary relief, but symptoms recurred.
Findings:
- Recurrent ventricular tachycardia and rest angina were resistant to procainamide.
- Aggressive anti-ischemic medical therapy led to resolution of the ventricular arrhythmias.
Implications:
- Anti-ischemic medication may be a crucial therapeutic option for ventricular arrhythmias caused by spontaneous myocardial ischemia.
- This case highlights the importance of addressing underlying ischemia in managing refractory ventricular tachycardia.
- Further research into anti-ischemic strategies for malignant ventricular arrhythmias is warranted.